FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of general formula (I), as well as to pharmaceutical compositions based thereon.
.
EFFECT: technical result is obtaining novel compounds having inhibitory activity on CYP11B2 enzyme.
23 cl
Title | Year | Author | Number |
---|---|---|---|
3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE DERIVATIVES USEFUL AS ALDOSTERONE SYNTHASE INHIBITOR | 2014 |
|
RU2695524C2 |
NOVEL 3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONES AND 2,3-DIHYDRO-ISOINDOLE-1-ONES | 2014 |
|
RU2689421C2 |
NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2018 |
|
RU2785126C2 |
N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
NEW ISOXAZOLIL ETHER DERIVATIVES AS PAM GABA A ALFA5 | 2019 |
|
RU2800160C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
PYRROLIDINE DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS | 2010 |
|
RU2561271C2 |
NEW ETERIAL DERIVATIVES OF ISOXAZOLE AS POSITIVE ALLOSTERIC MODULATORS OF THE GABA A ALFA 5 RECEPTOR | 2017 |
|
RU2772862C2 |
Authors
Dates
2019-07-04—Published
2014-05-26—Filed